Eosinophilic disease (BM)

ESOSINOPHIL_DISEASE

Hypereosinophilic syndrome: The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D72.1
Hospital discharge: ICD-9 2883
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D72.1
Cause of death: ICD-9 2883
Cause of death: ICD-8 $!$

375

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

375

diagram downward connector

Check minimum number of events None

375

diagram downward connector

Include endpoints None

375

diagram downward connector
ESOSINOPHIL_DISEASE

Extra metadata

First used in FinnGen datafreeze DF2
Parent code in ICD-10 D72
Name in latin Eosinophilia

Summary Statistics

Key figures

All Female Male
Number of individuals 375 196 179
Unadjusted prevalence (%) 0.11 0.10 0.11
Mean age at first event (years) 53.96 50.36 57.90

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ESOSINOPHIL_DISEASE – Eosinophilic disease (BM)
GWS hits: 1

Survival analyses between endpoints

Plot

before Eosinophilic disease (BM)
after Eosinophilic disease (BM)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Eosinophilic disease (BM)